Essentials - Management of Withdrawal - Opioids, Alcohol and Benzodiazepines
Essentials - Medical Complications of SUDs
Essentials - Cannabis use disorder: Prevalence and Consequences
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1 - 1/14/2023
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1 - 2/11/2023
The 8-hour Buprenorphine Training - PART 1 - 3/11/2023
The 8-hour Buprenorphine Training - PART 1 - 2/27/2023
The 8-hour Buprenorphine Training - PART 1 - 3/27/2023
The 8-hour Buprenorphine Training - PART 1 - 4/8/2023
STUDENT OSTEOPATHIC MEDICAL ASSOCIATION COURSE (SOMA) - The 8-hour Buprenorphine Training PART 1 - 03/04/2023
Innovation and Regulation: Improving Methadone Access While Maintaining Treatment Quality and Safety
Medicaid Managed Care Coverage for Substance Use Disorder Treatment
Why Preventing Drug Overdose Deaths is a Moving Target: Dynamic Shifts to the Opioid Crisis by Age, Race, Supply, Demand, and Geography
Reducing Health Harms for People who Inject Drugs in Appalachia - Research and Practice Partnerships in Syringe Service Programs
Isn't There a Better Way? Mitigating the Harms of Criminal Legal Involvement for Pregnant People Who Use Drugs
Addressing SUD/MAT in the Emergency Department Setting
Opioid Treatment Programs
Veterans and Active-Duty Military Issues in SUD
Criminal Justice Settings: Buprenorphine & Fentanyl in E.R. and Adult Drug Treatment Courts, Jail and Prison
DEA- Addiction Medicine Essentials Course- AOA/AOAAM
Opioid Use Disorder, Depression & Suicide: Overlapping Risk & Treatment Challenges
New Approaches to Methamphetamine Addiction and Psychosis
Operationalizing a Definition of Precipitated Withdrawal and the Absorption, Distribution, Metabolism, and Elimination of Illicitly Manufactured Fentanyl
Xylazine - An Introduction to a New Drug
Brixadi (buprenorphine-XR) for the Treatment of Opioid Use Disorder
The Evolution of Buprenorphine: Prescribing practices and efforts to increase MOUD access
Update on the U.S. Overdose Crisis: Which drugs, who is dying, and how do we save lives?
ORN Fall 2022 #1 - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
ORN Fall 2022 #2 - Case Studies and Q/A - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
ORN Fall 2022 #3 - Managing Opioid Complexity in Individuals with Serious Illness
ORN Fall 2022 #4 - Case Studies and Q/A - Managing Opioid Complexity in Individuals with Serious Illness
ORN Fall 2022 #5 - The State of Harm Reduction in the US: Progress, Barriers, and What's Next
ORN Fall 2022 #6 - Case Studies and Q/A - The State of Harm Reduction in the US: Progress, Barriers, and What's Next
ORN Spring 2022 #1 - The impact of illicit fentanyl use on opioid use disorder treatment
ORN Spring 2022 #2 - Case Studies and QandA: The impact of illicit fentanyl use on opioid use disorder treatment
ORN Spring 2022 #3 - Drugs, Stigma, and Health
ORN Spring 2022 #4 - Case Studies and QandA: Drugs, Stigma, and Health
ORN Spring 2022 #5 - The Fourth Wave: Addressing the Intertwined Fentanyl and Stimulant Overdose Crisis
ORN Spring 2022 #6 - Case Studies and QandA: The Fourth Wave: Addressing the Intertwined Fentanyl and Stimulant Overdose Crisis
Public Health Implications of Expanded Marijuana Programs
BAD MEDICINE: Mental Health and What the Opioid Epidemic Can Teach Us About Cannabis
Student Osteopathic Medical Association (SOMA) - The 8-hour MOUD Training - PART 1 - 11/18/2023 (counts towards the DEA’s 8-hour training requirement)
Cannabis and Adolescent Brain Development
Negative Impacts of High Potency THC on the Developing Brain and Mental Health - This Is NOT "Medicine"
Maternal Morbidity and Mortality Associated with Methamphetamine and Other Substance Use in the Perinatal Period
Opioid Use Disorder in Youth
Psychostimulant Toxicity
Exploring the Interface of Cannabis, Cannabinoids, and Opioid Use Disorder: Clinical Insights and Emerging Research
ED Treatment of Opioid Use Disorder: Truth, Trends and Treatments
Opioid Prescribing by Dentists and Oral Maxillofacial Surgeons
AOAAM Addiction Medicine Board Certification Review Course
Essentials - Acute Post-Operative Pregnancy Pain with At-Risk Women
Essentials - Adolescent Substance Use- How to Recognize Screen and Communicate
Essentials - Assessment and Management of Tobacco Use Disorders
Essentials - Assessment of Patients with Substance Use Disorders
Essentials - Co-occurring and Substance Induced Disorders
Essentials - Motivational Interviewing
Essentials - Sleep Problems Complicated by Substance Use Disorders
Essentials: 12 Step Program
Essentials: Addiction Medicine: The Elephant in the Middle of Healthcare
Essentials: Alcohol Use Problems: Recommendations for Medical Management
Essentials: General Principles of Drug Testing
Essentials: Neurobiology of Addictions
Essentials: Opioid Use Problems: Recommendations for Medical Management
Essentials: Pain and Addiction
Essentials: Prescribing Naloxone to Patients for Overdose Reversal
Essentials: Psychosocial Treatments for Substance Use Disorder
Essentials: Stimulant Use Disorder
2024 JAD Article 1 - Peer Review
2024 JAD Article 2 - Peer Review
2024 JAD Article 3 - Peer Review
2024 JAD Article 4 - Peer Review
2024 JAD Article 5 - Peer Review
2024 JAD Article 6 - Peer Review
2024 JAD Article 7 - Peer Review
2024 JAD Article 8 - Peer Review
2024 JAD Article 9 - Peer Review
2024 JAD Article 10 - Peer Review
ORN Webinar Fall 2021 #1 - Benzodiazepines and Opioid Maintenance Treatment: The Risks and the Benefits
ORN Webinar Fall 2021 #2 - Case Studies and Q&A: Benzodiazepines and Opioid Maintenance Treatment
ORN Webinar Fall 2021 #3 - COVID 19 Changes to Methadone Treatment at One Clinic in Central Pennsylvania
ORN Webinar Fall 2021 #4 - Case Studies and Q&A: COVID 19 Changes to Methadone Treatment at One Clinic in Central Pennsylvania
ORN Webinar Fall 2021 #5 - Treating Opioid Use Disorder in Pregnancy and the Perinatal Period
ORN Webinar Fall 2021 #6 - Case Studies and Q&A: Treating Opioid Use Disorder in Pregnancy and the Perinatal Period
Testimonies from the Trenches Series - Buprenorphine in Residential Treatment Settings (On-Demand)
Testimonies from the Trenches Series - Low-Barrier Buprenorphine Treatment (On-Demand)
Testimonies from the Trenches Series - Reconsidering the Role of Urine Drug Testing in OUD Treatment (On-Demand)
Testimonies from the Trenches Series - Safer Pain Management Practices for Patients with Opioid Use Disorder (On-Demand)
Disclaimer
Credit Statement
Credit Statement - AOA Category 1-A
AVAILABLE ON-DEMAND
Claim Credits & Course Materials